title: Identification of putative androgen receptor interaction protein modules: cytoskeleton and endosomes modulate androgen receptor signaling in prostate cancer cells.
abstract: We have developed a novel androgen receptor (AR) expression system in the 293 human embryonic kidney cell line that recapitulates AR biochemical activity as a steroid hormone receptor in prostate cancer cells. We used this system to identify putative AR-binding proteins in the cytosolic and nuclear compartments of mammalian cells using a large scale co-immunoprecipitation strategy coupled to quantitative mass spectrometry. For example, the heat shock 70 and 90 chaperones, which are known regulators of steroid hormone receptor, were identified as AR-binding proteins. AR purification enriched for proteins involved in RNA processing, protein transport, and cytoskeletal organization, suggesting a functional link between AR and these protein modules in mammalian cells. For example, AR purification in the nuclear compartment led to the specific enrichment of alpha-actinin-4, clathrin heavy chain, and serine-threonine protein kinase C delta. Short interfering RNA knockdown studies and co-transcriptional reporter assays revealed that clathrin heavy chain possessed co-activator activity during AR-mediated transcription, whereas alpha-actinin-4 and protein kinase C delta displayed both co-activator and co-repressor activity during AR-mediated transcription that was dependent upon their relative expression levels. Lastly immunohistochemical staining of prostate tissue showed that alpha-actinin-4 levels decreased in the nucleus of high grade cancerous prostate samples, suggesting its possible deregulation in advanced prostate cancers as previously observed in late stage metastatic breast cancers. Taken together, these findings suggest AR binds to specific protein modules in mammalian cells and that these protein modules may provide a molecular framework for interrogating AR function in normal and cancerous prostate epithelial cells.
authors.affiliation: University of California Davis Genome Center, Department of Pharmacology, UC Davis School of Medicine, Davis, California 95616, USA.
authors.forename: Rohini
authors.initials: R
authors.lastname: Jasavala
authors.forename: Harryl
authors.initials: H
authors.lastname: Martinez
authors.forename: Jaykumar
authors.initials: J
authors.lastname: Thumar
authors.forename: Armann
authors.initials: A
authors.lastname: Andaya
authors.forename: Anne-Claude
authors.initials: AC
authors.lastname: Gingras
authors.forename: Jimmy K
authors.initials: JK
authors.lastname: Eng
authors.forename: Ruedi
authors.initials: R
authors.lastname: Aebersold
authors.forename: David K
authors.initials: DK
authors.lastname: Han
authors.forename: Michael E
authors.initials: ME
authors.lastname: Wright
mesh_terms: D000727:Androgen-Binding Protein / Q000378:metabolism* / Q000502:physiology; D045744:Cell Line, Tumor; D016000:Cluster Analysis; D003599:Cytoskeleton / Q000378:metabolism* / Q000502:physiology; D011992:Endosomes / Q000378:metabolism* / Q000502:physiology; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007553:Isotope Labeling / Q000379:methods; D008297:Male; D008954:Models, Biological; D011471:Prostatic Neoplasms / Q000378:metabolism*; D011944:Receptors, Androgen / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: C410798:AR protein, human; D000727:Androgen-Binding Protein; D011944:Receptors, Androgen